ISMP Medication Safety Alert!®

Acute Care

A valuable resource to reduce medication error risk in your hospital

The ISMP Medication Safety Alert!® Acute Care is a digital newsletter, published every two weeks for hospital healthcare professionals.  Practitioners are encouraged to share this publication at committee meetings to initiate conversations about preventing similar errors within their organizations.

Subscription Options

Online access to twenty-five (25) issues per year. Subscriptions start with the first issue after the date of purchase. You will receive a reminder notice via email to renew your annual subscription before your subscription expires. Your subscription will not automatically renew.
Access to back issues are not included. Single issues are available for purchase. 

Special pricing for group purchase, contact ISMP.


Individual subscription: $200.00/year

Subscription Information

  • Online access for one (1) user

  • A user log-in required

  • PDF version available to download and redistribute internally

Organization subscription: $288.00/year

Subscription Information

  • Online access for up to 50 users within an organization

  • Individual log-in accounts required

  • Instructions to add users to a subscription will be emailed to the user purchasing the subscription

  • Subscriptions are location/site-based. If you have multiple locations/hospitals, please purchase an organization subscriptions for each site OR contact ISMP for group purchases

  • Please use your organization email address when subscribing


Browse Issues

This week's featured article: QuarterWatch (2016 Quarter 1 Data); Lessons Learned from Withdrawal of the Zecuity Patch; Patient Difficulties Using the Tanzeum Pen
This week's featured article: What Price Must We Pay for Safety? Excessive Cost of EPINEPHrine Auto-Injectors Leads to Error-Prone Use of Ampuls or Vials and Unprepared Consumers
This week's featured article: Quarter Watch Annual Report Issue: Trends and Changes in 2015 That Impact Medication Safety; More on Harm from Fluoroquinolones
This week's featured article: QuarterWatch™ Latest Edition: Cancer Risks with Biological Products for Psoriasis; Sudden Hearing Loss with Tadalafil and Sildenafil